EyePoint Announces Participation at Upcoming Investor Conferences and Scientific Meeting

$EYPTPress releaseSep 2, 2026, 7:00 AM ETRead the release

EyePoint will participate in three September investor conferences, with fireside chats at the Citi 2026 Biopharma Back to School Conference (September 9), the Cantor Global Healthcare Conference (September 10), and the Morgan Stanley Global Healthcare Conference (September 15), each available via webcast on the company's investor site.

Key figures

Drug Name: DURAVYU (EYP-1901, vorolanib intravitreal insert)
Phase Of Trial: Phase 3
Conference Dates: ["2026-09-09 Citi Biopharma Back to School","2026-09-10 Cantor Global Healthcare","2026-09-15 Morgan Stanley Global Healthcare"]
Upcoming Data Presentation: LUGANO Phase 3 first-time vision, anatomic, safety and treatment-burden outcomes vs aflibercept in nAMD, September 24, 2026 at The Retina Society meeting

AI analysis

Red flags2 · Pro

The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.

Upgrade to Pro · $49/mo billed annually

AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.